[1]朱桂平,乔 红,张 雷.益气活血开窍方联合西医常规治疗对脑梗死恢复期患者神经功能、血液流变学和血清炎症因子的影响[J].陕西中医,2024,(9):1203-1206.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.011]
　ZHU Guiping,QIAO Hong,ZHANG Lei.Effects of Yiqi Huoxue Kaiqiao decoction combined with conventional western medicine on neurological function,hemorheology and serum inflammatory factors in patients with cerebral infarction during convalescence[J].,2024,(9):1203-1206.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.011]
点击复制

益气活血开窍方联合西医常规治疗对脑梗死恢复期患者神经功能、血液流变学和血清炎症因子的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1203-1206
栏目:
临床研究
出版日期:
2024-09-05

文章信息/Info

Title:
Effects of Yiqi Huoxue Kaiqiao decoction combined with conventional western medicine on neurological function,hemorheology and serum inflammatory factors in patients with cerebral infarction during convalescence
作者:
朱桂平; 乔 红; 张 雷
(安徽医科大学附属宿州医院,安徽 宿州 234000)
Author(s):
ZHU Guiping; QIAO Hong; ZHANG Lei
(Department of Traditional Chinese Medicine,Suzhou Hospital Affiliated to Anhui Medical University,Suzhou 234000,China)
关键词:
脑梗死;  益气活血开窍方;  神经功能;  肢体运动功能;  血液流变学;  炎症
Keywords:
Cerebral infarction;  Yiqi Huoxue Kaiqiao decoction;  Neurological function;  Limb motor function;  Hemorheology;  Inflammation
分类号:
R 743.33
DOI:
DOI:10.3969/j.issn.1000-7369.2024.09.011
文献标志码:
A
摘要:
目的:探讨脑梗死恢复期患者在常规西医基础上予以益气活血开窍方的治疗效果。方法:将脑梗死恢复期患者103例随机分为对照组51例与观察组52例,分别予以常规西医治疗、益气活血开窍方联合西医治疗,两组均治疗8周。对两组美国国立卫生院卒中量表(NIHSS)、Fugl-Meyer运动功能量表(FMA)、改良Barthel指数(MBI)进行评估,对比两组血液流变学[全血黏度(高切)、血浆黏度、纤维蛋白原水平]和血清炎症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]; 并比较两组疗效和不良反应。结果:与对照组比较,观察组总有效率更高(86.54% 与 70.59%,P<0.05)。治疗后,与对照组比较,观察组NIHSS评分更低,FMA评分和MBI评分更高(P<0.05),且观察组全血黏度(高切)、血浆黏度、Fib水平和血清IL-6、TNF-α水平更低(P<0.05)。两组不良反应比较无统计学差异(P>0.05)。结论:脑梗死恢复期患者在常规西医基础上予以益气活血开窍方治疗有较好疗效,能够调节血液流变学,减轻炎症,促进神经功能恢复和肢体运动功能的提高。
Abstract:
Objective:To investigate the therapeutic effect of Yiqi Huoxue Kaiqiao decoction on patients with cerebral infarction at convalescent stage on the basis of conventional western medicine.Methods:A total of 103 cerebral infarction patients at recovery stage were divided into control group(51 cases)and observation group(52 cases)randomly.They were treated with conventional western medicine,Yiqi Huoxue Kaiqiao decoction combined with western medicine respectively.Both groups were treated for 8 weeks.The National Institutes of Health Stroke Scale(NIHSS),Fugl-Meyer motor function scale(FMA)and modified Barthel index(MBI)were evaluated in the two groups.The hemorheology [whole blood viscosity(high shear),plasma viscosity,fibrinogen level] and serum inflammatory factors [interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)] were compared between the two groups.The efficacy and adverse reactions of the two groups were compared.Results:The observation group's total effective rate of was higher(86.54% vs 70.59%,P<0.05)comparing with the control group.After treatment,compared with the control group,the observation group's NIHSS score was lower,the FMA score and MBI score were higher(P<0.05),and the whole blood viscosity(high shear),plasma viscosity,Fib level and serum IL-6 and TNF-α levels in the observation group were lower(P<0.05).The adverse reactions between the two groups shows no significant difference(P>0.05).Conclusion:Yiqi Huoxue Kaiqiao decoction on the basis of conventional western medicine has a good effect on patients with cerebral infarction in convalescence,which can regulate hemorheology,reduce inflammation,promote the recovery of neurological function and the improvement of limb motor function.

参考文献/References:

[1] 王陇德,刘建民,杨弋,等.我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):105-119.
[2] DONKOR E S.Stroke in the 21st century:A snapshot of the burden,epidemiology,and quality of life[J].Stroke Res Treat,2018,2018:3238165.
[3] 林秀慧,吴志敏,王逸如,等.芪仙通络方对脑梗死恢复期患者神经功能恢复的影响及机制[J].中国实验方剂学杂志,2021,27(23):118-124.
[4] 谭春凤,郑全成,徐琼,等.补阳还五汤配合温阳针灸法治疗老年缺血性脑卒中恢复期气虚血瘀证的疗效观察[J].中华中医药学刊,2023,41(7):230-234.
[5] 韩小磊,王峰,王伟民,等.益气活血中药对脑梗死血清NGF、BDNF含量以及神经功能缺损程度的影响[J].中华中医药学刊,2023,41(2):108-111.
[6] 闰振文,郑眉光,李梅.益气活血通络方对急性脑梗死大鼠炎症因子、氧化应激指标及神经细胞凋亡的影响[J].中国中医急症,2020,29(6):957-961.
[7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):662-682.
[8] 国家中医药管理局脑病急症科研组.中风辨证诊断标准(试行)[J].北京中医药大学学报,1994,17(3):64-66.
[9] 徐康丽,张金生,安兰花,等.基于隐结构结合关联规则网络探讨脑梗死恢复期的中医病机与治法[J].中药新药与临床药理,2023,34(6):841-848.
[10] 段国华,叶秋菊,张海燕,等.川芎龙蛭汤联合耳穴电探测贴压治疗脑梗死气虚血瘀证临床研究[J].陕西中医,2022,43(9):1000-1003.
[11] 张婷,齐婧,刘侃,等.温针灸联合逐瘀活血汤治疗脑梗死恢复期气虚血瘀证临床疗效观察[J].世界中医药,2023,18(12):1727-1731.
[12] 郝丽霞,张晋岳,贾跃进.李济春治疗中风病临证经验[J].世界中西医结合杂志,2016,11(6):778-780.
[13] 赵钟辉,郭蓉娟,冉超,等.基于代谢组学探讨补阳还五汤治疗脑梗死恢复期气虚血瘀证的效应机制[J].中西医结合心脑血管病杂志,2023,21(8):1390-1401.
[14] GAO H,HUANG N,WANG W,et al.Astragalus flavone induces proliferation and differentiation of neural stem cells in a cerebral infarction model[J].Med Sci Monit,2022,28:e933830.
[15] 姜林,李彬,臧运华,等.当归芍药散对血管性痴呆大鼠炎症因子及神经细胞凋亡的影响[J].陕西中医,2023,44(11):1532-1536.
[16] 洪艺勤,唐炳华,陈旭,等.丹参提取物对大鼠心肌缺血后血管新生的保护作用研究[J].环球中医药,2023,16(11):2186-2193.
[17] LI Y,LIN Y,SHI Z,et al.Safflower yellow pigment and Sanqi Panax notoginseng in the treatment of acute cerebral infarction:A systematic review,meta-analysis,and cost-effectiveness analysis[J].Ann Transl Med,2021,9(18):1407.
[18] 耿倩雯,胡健强,张东伟,等.凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、凝血酶时间、心肌指标检测在冠心病诊断中的意义[J].陕西医学杂志,2022,51(10):1309-1312.
[19] 丁宁,张卫峰,陈小勇,等.平均血小板体积、D-二聚体和纤维蛋白原降解产物与脑梗死及其病变程度的相关性研究[J].检验医学,2021,36(4):3384-3387.
[20] 刘颖,刘静,李韵,等.血清脂蛋白相关磷脂酶A2、淀粉样蛋白A及血浆纤维蛋白原联合检测在诊断急性脑梗死中的临床价值[J].中国急救复苏与灾害医学杂志,2022,17(12):1598-1601.
[21] 凌爽,冯月男,刘思莹,等.补阳还五汤对高脂血症模型大鼠血液流变学和血小板相关生物学指标的影响[J].中国药房,2021,32(7):801-806.
[22] YU L,ZHANG Y,CHEN Q,et al.Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2/STAT3 signaling pathway[J].Biomed Pharmacother,2022,149:112836.
[23] 庞刚,梁有明,秦国文,等.亚低温治疗对急性外伤性脑梗死患者炎性因子水平及神经功能的影响[J].川北医学院学报,2021,36(7):854-865.
[24] 汪步玲,张骏,关闪闪,等.脾脏体积变化及血清炎性因子对急性脑梗死严重程度的预测价值[J].中风与神经疾病杂志,2022,39(12):1060-1064.
[25] 金泉伟,邹兴菊.氯吡格雷联合奥扎格雷钠治疗后循环脑梗死对患者血液流变学、NIHSS评分、Barthel指数及血清炎症因子的影响[J].陕西医学杂志,2021,50(2):225-232.

相似文献/References:

[1]郭 辉,裴 育,熊伟华,等.血府逐瘀汤联合阿替普酶静脉溶栓对急性脑梗死患者 神经功能及日常生活能力的影响*[J].陕西中医,2019,(2):214.
　GUO Hui,PEI Yu,XIONG Weihua,et al.Effect of Xuefu Zhuyu decoction combined with intravenous thrombolysis on the neurological function and activities of daily living in patients with acute cerebral infarction[J].,2019,(9):214.
[2]陈 晨.补阳还五汤对急性脑梗死患者血管内皮生长因子、血管生成素2及神经功能影响的研究*[J].陕西中医,2019,(1):28.
[3]王艳民.开窍活血汤对脑梗死患者血清前白蛋白、MCP1及MMP9的影响*[J].陕西中医,2019,(1):34.
[4]贾东佩,李春雷△.调神通络针刺法对脑梗死后血管性痴呆患者血清BDNF、VEGF、MMP9的影响*[J].陕西中医,2019,(1):119.
　JIA Dongpei,LI Chunlei..Effect of Tiaoshen Tongluo acupuncture in patients with vascular dementia after cerebral infarction and its effects on serum BDNF, VEGF and MMP9[J].,2019,(9):119.
[5]周志梅,买 雷,李艳红.消栓肠溶胶囊治疗脑梗死疗效及对患者NIHSS评分的影响*[J].陕西中医,2019,(6):696.
　ZHOU Zhimei,MAI Lei,LI Yanhong..Effect of Xiaoshuan enteric-coated capsule on patients with cerebral infarction and its influence on NIHSS score of patients[J].,2019,(9):696.
[6]项广宇.化痰通络方治疗短暂性脑缺血发作后脑梗死疗效及对患者氧化应激和血清相关细胞因子水平的影响*[J].陕西中医,2019,(7):864.
[7]陈 静,陈 炜,伍 媛,等.小续命汤及其组分治疗急性脑梗死研究进展*[J].陕西中医,2019,(12):1818.
[8]赵月臣,马 兰.痰瘀阻络方联合丁苯酞治疗脑梗死急性期疗效及对患者脑血流灌注及血清6-k-PGF1a、Hcy、sICAM-1水平影响*[J].陕西中医,2020,(2):174.
　ZHAO Yuechen,MA Lan..Effect of phlegm stasis blocking collateral combined with butylphthalide on cerebral blood flow perfusion and serum 6-k-PGFla,Hcy and sICAM-1 level in patients with acute cerebral infarction[J].,2020,(9):174.
[9]黄英媛,宋振华△,徐焕杰,等.补阳还五汤联合梅花针叩刺治疗脑梗死偏瘫疗效研究*[J].陕西中医,2020,(6):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
　HUANG Yingyuan,SONG Zhenhua,XU Huanjie,et al.Clinical effect of Buyang Huanwu decoction combined with plum flower needle tapping on cerebral infarction hemiplegia[J].,2020,(9):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
[10]韩 慧,赖智勇,蒲建萍,等.头穴丛刺法联合川芎嗪对大鼠脑梗死后神经元突触重建的影响*[J].陕西中医,2020,(7):860.[doi:DOI:10.3969/j.issn.10007369.2020.07.006]
　HAN Hui,LAI Zhiyong,PU Jianping,et al.Effect of scalp acupuncture combined with ligustrazine on synaptic reconstruction of neurons after cerebral infarction in rats[J].,2020,(9):860.[doi:DOI:10.3969/j.issn.10007369.2020.07.006]

备注/Memo

备注/Memo:
基金项目:安徽省重大疑难疾病中西医协同攻关项目[皖中医药发展秘(2021)70号]; 安徽省中医药传承创新科研项目(2020CCYB23)
更新日期/Last Update: 2024-09-09